Prostate Cancer - Results from #22620

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer - Abstract August 1, 2013

Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging - Abstract July 31, 2013

Prostate-specific antigen kinetics under androgen deprivation therapy and prostate cancer prognosis - Abstract July 31, 2013

The present and future of prostate cancer urine biomarkers - Abstract July 31, 2013

Image-guided robotic interventions for prostate cancer - Abstract July 31, 2013

Prostate cancer screening and health care system distrust in Philadelphia - Abstract July 31, 2013

A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: A randomized controlled trial - Abstract July 31, 2013

African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: Should active surveillance still be an option for them? - Abstract July 31, 2013

Observation versus initial treatment for men with localized, low-risk prostate cancer: A cost-effectiveness analysis - Abstract July 31, 2013

Large Urology Group Practice Association (LUGPA) applauds the Physician's Caucus of the U.S. House of Representatives for their commitment to preserve patient access to independent, integrated medical services - Podcast - by Deepak A. Kapoor, MD July 31, 2013

The state of prostate MRI in 2013 - Abstract July 31, 2013

New therapeutics to treat castrate-resistant prostate cancer - Abstract July 31, 2013

Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-Year experience at Mount Sinai Medical Center - Abstract July 30, 2013

Serum testosterone levels after medical or surgical androgen deprivation: A comprehensive review of the literature - Abstract July 30, 2013

Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series - Abstract July 30, 2013

The role of focal therapy in the management of localised prostate cancer: A systematic review - Abstract July 30, 2013

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population - Abstract July 30, 2013

Pathologic examination of radical prostatectomies in men with very-low-risk disease at biopsy reveals distinct zonal distribution of cancer in African American men - Abstract July 30, 2013

PSA screening for prostate cancer: Why so much controversy? - Abstract July 30, 2013

GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update - Abstract July 30, 2013

Page 1132 of 1436